Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug use-results survey of COMLEX OTIC SOLUTION 1.5%
jRCT2031240245Recruiting
- Sponsor
- CEOLIA Pharma
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of levofloxacin in external otitis and otitis media, sponsored by CEOLIA Pharma. Primary endpoints: MIC range, MIC50 and 2 more. Started Jul 2024; status: recruiting.
02
Drugs
levofloxacin
03
Conditions
external otitisotitis media
Beyond the preview
Go deeper on jRCT2031240245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240245.